Use Of Derivatives With C-O-P Bonds In Patients With Kidney Failure

Use of a derivative containing C-O-P bonds in a controlled release form to treat patients with kidney failure. Moreover, it comprises the use of said derivatives together with other active substances, which particularly may be selected from a list comprising a calcimimetic, vitamin, phosphate binder...

Full description

Saved in:
Bibliographic Details
Main Authors SALCEDO ROCA, Carolina, JOUBERT, Pieter H, PERELLO BESTARD, Joan, FERRER REYNES, Miquel David, ISERN AMENGUAL, Bernat
Format Patent
LanguageEnglish
Published 08.04.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Use of a derivative containing C-O-P bonds in a controlled release form to treat patients with kidney failure. Moreover, it comprises the use of said derivatives together with other active substances, which particularly may be selected from a list comprising a calcimimetic, vitamin, phosphate binder, thiosulfate, bisphosphonate, pyrophosphate, citrate, diuretic, antihypertensive and anticholesteraemic agent. * 25 mg HAP U 75 mg HAP 5 g. A 130 mg HAP Y 300 mg HAP IP6 adsorbed (mg/g HAP) 0.1 0.3 1 3 10 Figure 1 IP6 adsorbed (mg/g HAP) 3 0 100 20o 300 400 500 Tiempo (min) Time (min) Figure 2
Bibliography:Application Number: AU20190201988